Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals
- PMID: 8009572
- DOI: 10.1097/00007691-199404000-00018
Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals
Abstract
Two independent studies showed that the 5-hydroxylation, but not the sulfoxidation, of omeprazole is more rapid in extensive metabolizers (EMs) than in poor metabolizers (PMs) of S-mephenytoin. In Caucasian, Chinese, and Korean PMs, the mean oral clearances were similar and not significantly different (85, 73, and 59 ml h-1 kg-1, respectively). However, the geometric mean clearance in Caucasian EMs (950 ml h-1 kg-1) was higher than in both Chinese EMs (426 ml h-1 kg-1, p < 0.05) and Korean EMs (446 ml h-1 kg-1, p < 0.01). The incidence of PMs of S-mephenytoin is higher in Chinese (14.6%) and Koreans (12.6%) than in Swedish Caucasians (3.3%). Therefore, the proportion of heterozygous compared to homozygous EMs is higher in Orientals than in Caucasians. This might explain the higher clearance of omeprazole in Caucasian EMs compared to the clearance of omeprazole in Chinese and Korean EMs of S-mephenytoin.
Similar articles
-
Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype.Pharmacogenetics. 1995 Dec;5(6):358-63. doi: 10.1097/00008571-199512000-00004. Pharmacogenetics. 1995. PMID: 8747407
-
Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19.Clin Pharmacokinet. 1995 Sep;29(3):192-209. doi: 10.2165/00003088-199529030-00005. Clin Pharmacokinet. 1995. PMID: 8521680 Review.
-
Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects.Pharmacogenetics. 1992 Feb;2(1):25-31. doi: 10.1097/00008571-199202000-00005. Pharmacogenetics. 1992. PMID: 1302040
-
5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.J Pharmacol Exp Ther. 2000 Nov;295(2):844-51. J Pharmacol Exp Ther. 2000. PMID: 11046127
-
[The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].Sheng Li Ke Xue Jin Zhan. 1995 Jan;26(1):23-8. Sheng Li Ke Xue Jin Zhan. 1995. PMID: 7604218 Review. Chinese.
Cited by
-
Appropriate first-line regimens to combat Helicobacter pylori antibiotic resistance: an Asian perspective.Molecules. 2015 Apr 8;20(4):6068-92. doi: 10.3390/molecules20046068. Molecules. 2015. PMID: 25856059 Free PMC article. Review.
-
Efficacy of S-pantoprazole 20 mg compared with pantoprazole 40 mg in the treatment of reflux esophagitis: a randomized, double-blind comparative trial.Dig Dis Sci. 2012 Dec;57(12):3189-94. doi: 10.1007/s10620-012-2297-y. Epub 2012 Jul 8. Dig Dis Sci. 2012. PMID: 22772870 Clinical Trial.
-
Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy.Eur J Clin Pharmacol. 2007 Aug;63(8):743-9. doi: 10.1007/s00228-007-0302-8. Epub 2007 Jun 13. Eur J Clin Pharmacol. 2007. PMID: 17565490 Clinical Trial.
-
Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Curr Drug Metab. 2010 Jan;11(1):4-84. doi: 10.2174/138920010791110917. Curr Drug Metab. 2010. PMID: 20302566 Free PMC article. Review.
-
Personalized Approach in Eradication of Helicobacter pylori Infection.Antibiotics (Basel). 2022 Dec 21;12(1):7. doi: 10.3390/antibiotics12010007. Antibiotics (Basel). 2022. PMID: 36671208 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources